The Prospective Non-randomized Case-control Study From Real-world Lung Cancer Patients

NCT04909164 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Immunnotherapy group

Sponsor

Samsung Medical Center

Collaborators

[object Object]